Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Operating Activities
Net income	$ 26,560	$ 20,993
Adjustments to reconcile net income to net cash provided by operating activities:
Accretion of Discount	(2,599)	(3,694)
Provision for loan losses	1,798	3,749
Depreciation of premises and equipment	3,011	2,852
Deferred income tax expense	2,615	3,268
Net periodic employee benefit cost	286	378
Realized investment securities gains	(901)	(93)
Stock-compensation expense	889	703
Increase in value of bank-owned life insurance	(1,520)	(1,608)
Loans originated for sale	(2,454)	(15,656)
Proceeds from the sale of loans originated for sale	3,129	19,576
Gain on sale of loans	(84)	(427)
Change in accrued interest receivable	(861)	(189)
Change in other assets	(5,986)	15,945
Change in other liabilities	(9,919)	(11,469)
Net Cash Provided by Operating Activities	13,964	34,328
Investing Activities
Proceeds from sales of securities available-for-sale	1,660	18,438
Proceeds from maturities and calls of securities available-for-sale	26,237	60,543
Proceeds from maturities and calls of securities held-to-maturity	1,254	9,188
Purchases of securities available-for-sale	(13,530)	(22,335)
Payments to Acquire Held-to-maturity Securities	(10,226)	0
Net decrease (increase) in loans	29,225	(11,732)
Purchases of premises and equipment	(664)	(3,276)
Acquisitions, net of cash acquired	0	(21,852)
Net Cash Provided by Investing Activities	33,956	28,974
Financing Activities
Net increase in noninterest-bearing deposits	7,163	37,908
Net (decrease) increase in interest-bearing deposits	(5,638)	6,291
Net (decrease) increase in short-term borrowings	(4,656)	9,697
Purchases of treasury stock	(8,363)	0
Proceeds from exercise of stock options, net of tax benefit	553	1,397
Dividends paid	(12,115)	(11,255)
Net Cash (Used in) Provided by Financing Activities	(23,056)	44,038
Increase in Cash and Cash Equivalents	24,864	107,340
Cash and cash equivalents at beginning of period	85,876	84,994
Cash and Cash Equivalents at End of Period	$ 110,740	$ 192,334